Glucose Clinical Trials

4 recruiting

Glucose Trials at a Glance

117 actively recruiting trials for glucose are listed on ClinicalTrialsFinder across 6 cities in 30 countries. The largest study group is Not Applicable with 74 trials, with the heaviest enrollment activity in Aurora, Boston, and New York. Lead sponsors running glucose studies include Georgia State University, National Taiwan University Hospital, and Old Dominion University.

Treatments under study

About Glucose Clinical Trials

Looking for clinical trials for Glucose? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glucose trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glucose clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 117 trials

Recruiting
Phase 2

Regulation of Endogenous Glucose Production by Central KATP Channels

Diabetes MellitusGlucose Metabolism Disorders
Albert Einstein College of Medicine100 enrolled1 locationNCT03540758
Recruiting
Not Applicable

Comparative Efficacy of Intra-articular vs. MRI-guided Extra-articular Dextrose Injections in Knee Osteoarthritis Management

MRIKnee OsteoarthritisRehabilitation+3 more
Shin Kong Wu Ho-Su Memorial Hospital60 enrolled1 locationNCT06755697
Recruiting
Not Applicable

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

Insulin ResistanceHyperinsulinismDepression+5 more
Colorado State University300 enrolled2 locationsNCT05543083
Recruiting
Not Applicable

Effect of Changes in Carbohydrate Intake Patterns on Glucose Control in Patients With Type 1 Diabetes

Type 1 DiabetesDiet InterventionGlucose Control
Yang Tao80 enrolled1 locationNCT06273631
Recruiting
Not Applicable

Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal Women

Post-menopauseGlucose Monitoring, ContinuousWhole Body Protein Metabolism+1 more
Nutrition 21, Inc.60 enrolled1 locationNCT07402382
Recruiting
Not Applicable

Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health

Sedentary BehaviorCardiometabolic Risk FactorsBlood Pressure+1 more
Columbia University324 enrolled1 locationNCT05353322
Recruiting
Phase 2

Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)

Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
University Hospital Schleswig-Holstein390 enrolled2 locationsNCT07286747
Recruiting
Not Applicable

Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

Cognitive DysfunctionPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)+3 more
Leeds Beckett University70 enrolled1 locationNCT07073781
Recruiting
Not Applicable

Peanuts for Cardiometabolic, Brain, and Intestinal Health

AdultPrediabetesCognition+5 more
Georgia State University72 enrolled1 locationNCT06867198
Recruiting
Not Applicable

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

Arterial StiffnessBody CompositionAdult+9 more
Georgia State University30 enrolled1 locationNCT06735651
Recruiting
Not Applicable

Pilot Assessment of Continuous Glucose Monitor for Post-meal Glucose Responses to Herbs and Spices.

Post-prandial Glucose Response
University of Alabama at Birmingham10 enrolled1 locationNCT07254624
Recruiting
Not Applicable

Glucose Profiles in Women With Polycystic Ovary Syndrome

Insulin ResistancePolycystic Ovary SyndromeGlucose Profile+1 more
Centre Hospitalier Universitaire, Amiens80 enrolled1 locationNCT07483723
Recruiting
Not Applicable

A Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar on Blood Glucose Control in a Healthy Adult Population

Blood GlucoseHealthy
Bragg Live Food Products24 enrolled1 locationNCT07043478
Recruiting
Not Applicable

A Study to Evaluate the Effects of a Prebiotic Soda on Glycemic Control in Adults

Blood Glucose Control
Olipop, PBC224 enrolled1 locationNCT07298135
Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting
Not Applicable

Assessing the Effects of Cool Roofs on Indoor Environments and Health

Sleep QualityDepressionDehydration+22 more
Aditi Bunker3,200 enrolled5 locationsNCT06579950
Recruiting
Not Applicable

Impact of Supplementation in Improving Metabolic Health Outcomes (ISMOS) Study

Mental HealthGlucose Control
Institute for Human Development and Potential (IHDP), Singapore400 enrolled1 locationNCT07433049
Recruiting
Not Applicable

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

Physical InactivityDiabetes Mellitus, Type 2Hyperglycemia+2 more
University of Pittsburgh30 enrolled1 locationNCT07270016
Recruiting
Not Applicable

Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes

Gestational Diabetes Mellitus in PregnancyGlucose Intolerance During PregnancyNon-nutritive Sweeteners Consumption in Pregnancy and/or Lactation
George Washington University324 enrolled1 locationNCT06548828
Recruiting
Phase 3

Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients

Sodium-glucose Transport Protein Two Inhibitor (SGLT2),Metabolic Deficits Caused by Antipsychotics
Tanta University40 enrolled1 locationNCT05669742